| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Jan 8, 2025 | Denali Therapeutics Inc. | Director | Sell | 40.0 | -3,339 | -0.41% | ✗ | $69.5K |
| Dec 31, 2024 | Jan 3, 2025 | Denali Therapeutics Inc. | Director | Sell | 35.0 | -30,000 | -3.57% | ✓ | $607.5K |
| Sep 30, 2024 | Oct 2, 2024 | Denali Therapeutics Inc. | Director | Sell | 35.0 | -30,000 | -3.44% | ✓ | $870.9K |
| Aug 20, 2024 | Aug 22, 2024 | Denali Therapeutics Inc. | Director | Sell | 51.3 | -1,727 | -0.20% | ✗ | $41.1K |
| Jun 13, 2024 | Jul 3, 2024 | Denali Therapeutics Inc. | Director | Sell | 35.0 | -30,688 | -3.10% | ✓ | $678.7K |
| Apr 1, 2024 | Apr 2, 2024 | Denali Therapeutics Inc. | Director | Sell | 23.8 | -92,500 | -9.34% | ✓ | $1.9M |
| Feb 13, 2024 | Feb 15, 2024 | Denali Therapeutics Inc. | Director | Sell | 43.8 | -2,750 | -0.28% | ✗ | $47.5K |
| Jan 5, 2024 | Jan 9, 2024 | Denali Therapeutics Inc. | Director | Sell | 40.0 | -3,208 | -0.32% | ✗ | $62.3K |
| Aug 21, 2023 | Aug 23, 2023 | Denali Therapeutics Inc. | Director | Sell | 51.3 | -1,419 | -0.14% | ✗ | $32.1K |
| Feb 13, 2023 | Feb 15, 2023 | Denali Therapeutics Inc. | Director | Sell | 40.0 | -2,119 | -0.21% | ✗ | $63.8K |
| Feb 8, 2023 | Feb 10, 2023 | Denali Therapeutics Inc. | Director | Sell | 51.3 | -1,377 | -0.14% | ✗ | $42.5K |
| Jan 5, 2023 | Jan 9, 2023 | Denali Therapeutics Inc. | Director | Sell | 40.0 | -2,970 | -0.30% | ✗ | $84.5K |
| Aug 19, 2022 | Aug 23, 2022 | Denali Therapeutics Inc. | Director | Sell | 40.0 | -2,253 | -0.22% | ✗ | $74.8K |
| Feb 11, 2022 | Feb 15, 2022 | Denali Therapeutics Inc. | CFO | Sell | 40.0 | -2,560 | -0.26% | ✗ | $88.8K |
| Feb 9, 2022 | Feb 11, 2022 | Denali Therapeutics Inc. | CFO | Sell | 51.3 | -1,296 | -0.13% | ✗ | $48.1K |
| Jan 5, 2022 | Jan 7, 2022 | Denali Therapeutics Inc. | CFO | Sell | 40.0 | -2,225 | -0.23% | ✗ | $99.6K |
| Aug 19, 2021 | Aug 23, 2021 | Denali Therapeutics Inc. | CFO | Sell | 40.0 | -2,285 | -0.24% | ✗ | $113.3K |
| Mar 15, 2021 | Mar 16, 2021 | Denali Therapeutics Inc. | CFO | Sell | 27.5 | -50,000 | -5.01% | ✓ | $3.1M |
| Feb 16, 2021 | Feb 18, 2021 | Denali Therapeutics Inc. | CFO | Sell | 32.5 | -50,000 | -4.77% | ✓ | $3.3M |
| Feb 11, 2021 | Feb 16, 2021 | Denali Therapeutics Inc. | CFO | Sell | 40.0 | -3,035 | -0.29% | ✗ | $213.5K |
| Feb 7, 2021 | Feb 11, 2021 | Denali Therapeutics Inc. | CFO | Sell | 47.5 | -1,448 | -0.15% | ✗ | $108.1K |
| Jan 15, 2021 | Jan 20, 2021 | Denali Therapeutics Inc. | CFO | Sell | 32.5 | -50,000 | -4.95% | ✓ | $3.6M |
| Aug 20, 2020 | Aug 24, 2020 | Denali Therapeutics Inc. | CFO | Sell | 47.5 | -1,954 | -0.19% | ✗ | $64.2K |
| Mar 30, 2020 | Apr 1, 2020 | Denali Therapeutics Inc. | CFO | Sell | 51.3 | -1,428 | -0.14% | ✗ | $27.8K |
| Aug 20, 2019 | Aug 22, 2019 | Denali Therapeutics Inc. | CFO | Sell | 51.3 | -1,977 | -0.20% | ✗ | $36.7K |